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Glioblastoma is the most frequent and malignant brain tumor. Recurrence is inevitable and
most likely connected to tumor invasion and presence of therapy resistant stem-like tumor
cells. The aim was therefore to establish and characterize a three-dimensional in vivo-like in
vitro model taking invasion and tumor stemness into account.
Methods
Glioblastoma stem cell-like containing spheroid (GSS) cultures derived from three different
patients were established and characterized. The spheroids were implanted in vitro into rat
brain slice cultures grown in stem cell medium and in vivo into brains of immuno-compro-
mised mice. Invasion was followed in the slice cultures by confocal time-lapse microscopy.
Using immunohistochemistry, we compared tumor cell invasion as well as expression of
proliferation and stem cell markers between the models.
Results
We observed a pronounced invasion into brain slice cultures both by confocal time-lapse
microscopy and immunohistochemistry. This invasion closely resembled the invasion in
vivo. The Ki-67 proliferation indexes in spheroids implanted into brain slices were lower
than in free-floating spheroids. The expression of stem cell markers varied between free-
floating spheroids, spheroids implanted into brain slices and tumors in vivo.
Conclusion
The established invasion model kept in stem cell medium closely mimics tumor cell invasion
into the brain in vivo preserving also to some extent the expression of stem cell markers.
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The model is feasible and robust and we suggest the model as an in vivo-like model with a
great potential in glioma studies and drug discovery.
Introduction
Glioblastomas are the most malignant brain tumors with inevitable tumor recurrence after
treatment. Two of the crucial factors believed to be responsible for tumor recurrence are the
invasive properties of these tumors [1] combined with the treatment resistant tumor stem-like
cells [2–4].
Glioblastomas have pronounced invasive properties [1] with tumor cells often spreading
into corpus callosum and reaching the contralateral hemisphere or other distant brain regions
[5]. The invasive cells escape surgery and changes in the invasive cells influencing apoptosis
and proliferation may explain why they survive chemotherapy [6]. Similar mechanisms might
explain therapeutic resistance of tumor stem-like cells towards both chemotherapy [7] and
radiation [2, 8]. Interestingly, studies [9, 10] have suggested the invasive cells to have stem-cell
properties, being more aggressive than their non-invasive counterpart [11]. In vivo-like in vitro
models for investigation of invasion integrating the role of tumor stem-like cells into the mod-
els are therefore very import, but may have several limitations. In some studies migration on
the bottom of plastic plates with different coatings have been used [12, 13] as well as Boyden
chamber assays monitoring cell invasion through a membrane [14, 15]. A more in vivo-like
model would be to introduce the tumor cells into cultured brain tissue. Hereby, the structure of
the brain is preserved and a more optimal microenvironment for studies of tumor cell invasion
is created.
The aim of the present study was therefore to establish and evaluate a tumor stem cell-based
in vitro invasion model by implanting glioblastoma stem cell-like containing spheroids (GSS)
into rat organotypic brain slices cultured in stem cell promoting medium. This model com-
prises the use of the spheroid model used in glioma stem-cell research [16–19] and the brain
slice culture model used extensively in neuroscience [20–23]. In order to evaluate the model,
invasion in the in vitro model was compared with invasion in the in vivo situation, xenograft-
ing tumor cells from GSS into the brain of immunodeficient mice. Moreover, an immunohisto-
chemical comparison of in vitro cultured free-floating GSS, in vivo implanted GSS and GSS
implanted in vitro was performed, hypothesizing a possible therapeutically relevant phenotypic
shift related to proliferative potential and tumor stem cell properties.
Material and Methods
Tumor cell lines and primary tumor tissue
Glioblastoma tissue was collected and processed by manual dissociation into small tissue frag-
ments. These fragments were cultured until they rounded up to form spheroids, where after
the spheroids were trypsinated and allowed to form new spheroids. Three glioblastoma GSS
cultures (T78, T86 and T87) were established in our laboratory [17] and used in the present
study (T78 is referred to as GBM5 and T86 as GBM9 in [17]). Besides the GSS cultures the
commercial glioblastoma cell line U87 (from European Collection of Cell Cultures (ECACC))
was used. All cell lines were cultured in serum-free medium composed of Neurobasal A (Invi-
trogen), 2% B27 supplement without vitamin A (Invitrogen), N2 (Invitrogen), 1% glutamine
(Cambrex), 20 ng/mL EGF (Sigma-Aldrich), 20 ng/mL bFGF (Trichem A/S), and 1% penicil-
lin-streptomycin (Cambrex). The cells were cultured at 36°C in a standard tissue culture incu-
bator (95% humidity, 95% air, and 5% CO2). In order to determine the growth rates, cells were
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seeded in a 6-well plate (45000 cells/well) in 2 ml serum-free medium. The cell numbers were
estimated in triplicates at day 1–5. The three GSS cultures were further characterized by a
spheroid formation assay at clonal density [24, 25], karyotyping, a differentiation assay [24,
25], mIDH1 immunohistochemistry [26, 27] and MGMT analyses (QIAamp1DNA FFPE Tis-
sue kit, the EpiTect Plus DNA Bisulfite Kit and MGMT Pyro kit, all Qiagen) as well as by in
vivo xenografting of the cells into immunodeficient mice. Molecular subtypes were determined
by single sample prediction using nearest centroid method reported by Verhaak et al. [28]. For
T87 this resulted in a very clear proneural subtype (CC = 0.48) and for T86 a classical subtype
(CC = 0.12), whereas T78 was of mesenchymal subtype (CC = 0.11). Part of the characteriza-
tion comprising the capability of spheroid formation in vitro at clonal density and tumor for-
mation in vivo has previously been published for T78 and T86 [17].
Organotypic brain slice cultures and co-cultures
Organotypic corticostriatal slice cultures were prepared by the interface method [23, 25, 29] and
grown for the first three days in a serum-based culture medium as earlier described [23, 29]. There-
after the medium was changed to serum-free medium as used for culturing the GSS cultures.
Spheroids (200–400 μm) were incubated in 25 μg/ml DiI solution (DiI, Molecular Probes,
Invitrogen) for 24 h, washed, and implanted into the brain slice cultures in the area between
cortex and striatum close to corpus callosum. To enable capture and correct placement onto
the brain slice cultures only spheroids of 200–400 μmwere used. The tumor cells were visual-
ized using confocal microscopy (Nikon, Inverted Microscope, ECLIPSE TE2000-E with time-
lapse function and perfect focus system). After 1 h of incubation confocal z-stacks with 20 μm
steps were recorded, before superimposing the z-stacks to one image representing the entire
spheroid. This procedure was repeated at day 3 and day 6, where after the co-cultures were
fixed in 10% formalin and paraffin embedded.
Additionally, time-lapse experiments were performed following the in vitro invasion of
tumor cells into the brain slice cultures using DiO labeled T78 and T86 spheroids (DiO, Molec-
ular probes, Invitrogen). A z-stack was recorded every half hour for 11 hours and 30 minutes
and hereafter every hour for 48 hours. This resulted in time-lapse movies showing the tumor
cell invasion into the brain tissue in the first approximately 60 hours after implantation. The
co-cultures were cultured in a CO2 Microscope Cage Incubator (Okolab, Italy) (36°C, 95%
humidified air, and 5% CO2) mounted on the confocal microscope.
Xenograft model
Female Balb c nu/nu mice 7–8 weeks of age were anesthetized and tumor cells injected into the
brain as earlier described [17]. Two survival protocols were used to monitor tumor growth. In
the first protocol (max survival), the mice were euthanized upon symptoms and the brains
investigated. In the second protocol (short survival), we aimed to investigate an earlier stage of
tumor growth and mice were euthanized 30 days after implantation. The brains were removed
immediately after death and fixed in 10% formalin for 24 h. Before paraffin embedding the
brains were divided by a coronal section at the injection site in an anterior and posterior part.
Histological sections of the resulting paraffin blocks included two coronal sections of the brain.
Measurements in confocal images
After superimposing the confocal z-stacks, the area of the spheroids was measured using the
software Visiomorph (Visiopharm, Hørsholm, Denmark). The spheroids were outlined at the
spheroid boarder identifying the beginning of the invasion zone. The area of the invasive cells
was also measured in Visiomorph using a classifier identifying the area of DiI staining
Stem-Cell Based Glioblastoma Invasion Model
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representing only the invasive cells and not the spheroids. The invasion distance in the confocal
images was not measurable because of the small field of view.
Measurements in histological sections
The tissue sections stained with vimentin and CD56 were scanned using the whole slide scan-
ner (NanoZoomer 2.0-HT slide scanner, Hamamatsu). The area of the spheroids in vitro and
the tumors in vivo were measured using the program NanoZoomer Digital Pathology Version
2.3.11 from Hamamatsu. Using an area tool the spheroid or bulk tumor area without invasion
were outlined and measured. The invasion area was measured as being the tumor cell area
found outside the spheroids or tumor bulk using the software Visiomorph by making a classi-
fier identifying the area of positive vimentin and CD56 staining subtracting the area of the
spheroid or tumor bulk. The longest invasion distance was found using a linear measurement
tool, measuring the perpendicular distance from the border of the spheroid or tumor bulk to
the invasive front of the tumors.
Immunohistochemistry
Immunohistochemical analysis was carried out on the paraffin-embedded spheroids, mice
brains from in vivo xenografts and co-cultures as described previously [23, 30, 31] using the
antibodies vimentin, CD56, CD133, nestin, podoplanin and Ki-67. The Ki-67 labeling index
(Ki-67 LI) was determined using the software program Tissuemorph (Visiopharm, Hørsholm,
Denmark). The stem cell markers were assessed by semi-quantitative scoring from 0–3, with 0
being negative staining, 1 weak staining, 2 moderate staining and 3 extensive staining. The
staining of the invasive cells was not scored but it was investigated whether positive cells were
found outside the spheroids.
Ethics
The official Danish ethical review board named the Regional Scientific Ethical Committee of the
Region of Southern Demark approved the use of human glioma tissue (permission J. No. S-VF-
20040102) in the current study. Written informed consent was obtained from all participants.
The use of animals for organotypic brain slice cultures was approved by The Animal Experi-
ments Inspectorate in Denmark (permission J. No. 2008/561-1572). The rats (newborn wistar
rats, Taconic Denmark, n = 53) were decapitated and the brains were removed.
The use of animals for glioblastoma mice (Female Balb c nu/nu mice 7–8 weeks, Taconic
Denmark, n = 21) xenografts was approved by The Animal Experiments Inspectorate in Den-
mark (permission J. No. 2008/561-1572 and J. Nr. 2013-15-2934-00973). Mice were anesthe-
tized by a subcutaneous injection with a mixture of hypnorm (fentanyl, 0,315 mg/ml;
fluanisone, 10 mg/ml) and midazolam (0.12 ml/10g). The mice were euthanized in a carbon
dioxide chamber upon symptoms such as weight loss (20% loss of body weight) or general
poor state including lethargy, hunched posture and failure to groom.
The animals were housed according to national guideline (National declaration for animal
experiments 2013), and had free access to food and water.
Statistics
Data were analyzed using one-way ANOVA with Bonferroni post test to compare all data sets.
Statistical significance was defined as P<0.05, P<0.01, P<0.001. The survival of the mice
in the in vivo xenograft model was analyzed using a Kaplan-Meier plot. All statistics were car-
ried out using Graph Pad Prism 5.0 (Graphpad Software, San Diego, California USA).
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Results
In vitro characterization of the GSS cultures
All three GSS cultures formed tumor spheroids at passage numbers 5 to 12 used in the present
study (Fig 1A–1C). The tumor cells were all derived from IDH1-negative tumors suggesting
Fig 1. Characterization of GSS cultures. The three GSS cultures were cultured in serum-free medium as
spheroids, which upon trypsination to single cells developed new spheroids (A-C). Cells were seeded and the
cell number estimated at day 1–5 (n = 3) (D-F). Differentiation assays were performed showing expression of
the astrocytic marker GFAP (G-I) and the neuronal marker MAP2 (J-L), here illustrated for T78. The MGMT
status for each culture was determined by PCR and T78 and T87 were found to be methylated whereas T86
was unmethylated (M). All three GSS cultures were derived from IDH1-negative tumors representing primary
glioblastomas (M). Scalebar 100 μm (A-C) and 50 μm (J-L).
doi:10.1371/journal.pone.0159746.g001
Stem-Cell Based Glioblastoma Invasion Model
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that they were primary glioblastomas (Fig 1M) [32]. Upon karyotyping the three cell lines all
showed gain of chromosome 7 and in T86 and T87 loss of chromosome 10, characteristics
commonly observed in glioblastomas. The cell growth of T87 and T86 was similar, whereas
T87 had a significant higher growth rate (Fig 1D–1F). For comparison of growth rates of all
GSS cultures and U87 see supplementary data (S1 Fig). Hypermethylated CpG islands were
found in the MGMT promoter region of U87, T78 and T87 but not for T86 (Fig 1M). The dif-
ferentiation assay (data shown for T78) showed differentiation into the astrocytic and neuronal
lineage as identified by GFAP (Fig 1G–1I) and MAP2 (Fig 1J–1L), positive cells, respectively.
Confocal imaging of migrating tumor cells
Confocal images of the DiI-labeled spheroids implanted into brain slice cultures were recorded
and supposed invasion was seen for all three GSS cultures and for the U87 cell line (Fig 2A–
2L). The area of U87 increased significantly from day 0 to day 3 and 6 (Figs 2A–2C and 3A),
whereas only a slight increase in the area of the GSS cultures T78 (Figs 2D–2F and 3A), T86
(Figs 2G–2I and 3A) and T87 (Figs 2J–2L and 3A) was significant for T78 and T86 on day 6. A
small but significant increase in area of the supposedly invasive cells was seen for U87 after 6
days (Fig 3B). For T78, T86 and T87 (Fig 3B), there was a pronounced increase being signifi-
cant after both 3 and 6 days (Fig 3B).
Time-lapse movies showed clearly how cells migrated into the brain tissue, but cellular reor-
ganization in the center of the spheroids was also revealed. Furthermore, what appeared as cell
divisions were seen for T86 (S2 Fig).
Immunohistochemical evaluation of expression of glial and neuronal
markers in brain slice cultures
In both the cortex and striatum of brain slice cultures, cells with astroglial and neuronal mor-
phologies expressed the astrocytic marker GFAP and the neuronal markers MAP2 and NeuN,
respectively suggesting a normal cell composition of both brain regions (S3 Fig).
Immunohistochemical detection of tumor cell invasion in vitro
After culturing, three μm sections of co-cultures were immunohistochemically stained with
anti-human vimentin and CD56 (Fig 4). The borders of the U87 spheroids were well defined
and no invasion was seen in the brain slice cultures. The U87 spheroids stained positive for
vimentin (Fig 4A) but was negative for CD56 (Fig 4B). In contrast an invasive tumor cell phe-
notype with elongated cell morphology and membrane protrusions was derived from all GSS
cultures (Fig 4C, 4D and 4F–4H). Histology revealed that spheroids implanted into brain slice
cultures appeared viable after implantation as seen by the nuclear counter staining (Fig 4 and
S4–S7 Figs) and both central and peripheral aspects of the spheroids displayed proliferative
activity (S4 Fig).
The T78 spheroids stained positive for both vimentin (Fig 4C) and CD56 (Fig 4D). The T86
spheroids stained positive for CD56 (Fig 4F) but were negative for vimentin (Fig 4E). The
implantation of T87 into the brain slice cultures was difficult, since some of the spheroids
tended to fragment upon implantation into the brain slice cultures. These spheroids were
therefore placed on top of the slice cultures instead of being embedded into the tissue. This
may explain the less well defined margin of these spheroids (Fig 4H) in contrast to what was
seen for T78 and T86 (Fig 4D and 4F). The invasion of T87 into the brain tissue, however,
seemed to be more pronounced. T87 stained positive for both vimentin (Fig 4G) and CD56
(Fig 4H) but the vimentin staining was not found in all tumor cells compared to CD56.
Stem-Cell Based Glioblastoma Invasion Model
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Fig 2. Confocal images of spheroid invasion.Confocal z-stacks were recorded on day 0, one hour after implantation of DiI-
labeled spheroids into the brain slice cultures and after 3 and 6 days. The z-stacks were superimposed into one image
representing the entire spheroid. The glioma cell lines U87 showed no particular invasion of cells into the brain slice cultures
Stem-Cell Based Glioblastoma Invasion Model
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No significant differences were found between the spheroid areas of the different cultures
(Fig 4I) confirming that the intention of implanting spheroids of similar size was obtained. The
invasion area of T87 was significant larger than the areas for T78, T86 and U87 (Fig 4J). The
longest invasion distance was obtained for T87 as well (Fig 4K).
Tumor development and invasion in mice
Two protocols of implantation were used. In the first protocol (max survival) the mice were
implanted with U87 and the three GSS cultures and allowed to live until symptoms appeared.
To observe the tumors at an earlier stage of development, a second protocol (short survival)
was used. Only GSS cultures were implanted since the animals were euthanized on day 30 after
implantation (Fig 5).
With the first protocol, mice implanted with U87 cells were the first to have symptoms and
were euthanized already after 19 days. Mice implanted with the GSS culture T87 had symptoms
after 41 days. Two of the three mice implanted with T87 died before being euthanized resulting
in a tissue quality not suitable for immunohistochemical staining. Mice implanted with T78
were euthanized after 89 days, whereas the mouse with T86 was euthanized after 149 days.
Two of the three mice implanted with T86 died after surgery (Fig 5O). Thus survival curves
should be used with caution due to the low number of mice included.
All tumors were stained with anti-human vimentin and anti-human CD56 antibodies and
the expression pattern of the antibodies for each cell culture were identical to the pattern found
in the in vitro model (Figs 4A–4H and 5A–5N), although the immunohistochemical stainings
is only indicative due to the low number of mice. U87 grew as a solid tumors comprising the
majority of one hemisphere without any invasive characteristics (Fig 5A), whereas the three
GSS cultures in the max survival protocol all formed large infiltrative tumors migrating
through the corpus callosum to the contralateral hemisphere (Fig 5C, 5E, 5I, 5K and 5M). In
the max survival protocol T86 formed the largest tumor followed by T87, T78 and U87 (Fig
5P). In the short survival protocol T87 formed tumors approximately having the size of the
(A-C), whereas the three GSS cultures all showed pronounced invasion of tumor cells into the brain tissue (D-L). Scalebar
100 μm.
doi:10.1371/journal.pone.0159746.g002
Fig 3. Quantitation of area and invasion in confocal images. The spheroid area was measured in the confocal images on day 0, 3 and 6 (T78:
n = 48, T86: n = 73, T87: n = 21, U87: n = 21) (A) as well as the invasion area outside the spheroid (B). Data are shown as means ± SEM, and
statistical significance *P<0.05, **P<0.01, ***P<0.001 was investigated using ANOVAwith Bonferroni correction for comparison with day 0.
doi:10.1371/journal.pone.0159746.g003
Stem-Cell Based Glioblastoma Invasion Model
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tumors developed in the max survival protocol but being significantly larger than the tumors
developed upon implantation with T78 and T86 (Fig 5Q). U87 was significantly smaller than
T87 but larger than both T78 and T86 (Fig 5Q). The same U87 data are shown on both graphs
(Fig 5P and 5Q) since mice implanted with U87 cells had a short max survival.
The invasion area and the distance to the invasive margin were measured in the tumors
developed using the short survival protocol and for U87 tumors using the max survival proto-
col. The invasion area of T87 was significant larger than the invasion area of T78, T86 and U87
(Fig 5R). Likewise, the distance of invasion was significantly longer for T87 compared to T78,
T86 and U87 (Fig 5S).
Fig 4. Invasion in the in vitro invasionmodel. Thin 3 μm sections of spheroids implanted into brain slice cultures were stained by immunostained using
anti-human vimentin (A, C, E, G) and CD56 (B, D, F, H) antibodies. Co-cultures with both U87 spheroids (A, B), T78 (C, D), T86 (E, F) and T87 spheroids (G,
H) were stained. Spheroid area (I), invasion area (J) and longest invasion distance (K) were measured on the immunostained sections (T78: n = 147, T86:
n = 98, T87: n = 35, U87: n = 36). Data are shown as means ± SEM, and statistical significance */$ P<0.05, **/$ $ P<0.01, ***/$ $ $ P<0.001 was
investigated using ANOVA with Bonferroni correction for comparison of all groups. $ is comparison of the GSS cultures to U87. Scalebar 100 μm (A-H).
doi:10.1371/journal.pone.0159746.g004
Stem-Cell Based Glioblastoma Invasion Model
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Fig 5. Tumor development in the in vivo xenografts. Two in vivo xenograft protocols were used for
implantation of U87 and the GSS cultures in nude mice. A “max survival” (A and B (n = 3), C and E (n = 3), G
and I (n = 1), K and M (n = 3)) and a “short survival” (D and F (n = 3), H and J (n = 3), L and N (n = 7)) protocol.
Stem-Cell Based Glioblastoma Invasion Model
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Comparison of proliferation and stem cell marker expression
Ki-67 positive nuclei were found in all spheroids, at the central tumor site in all xenografts and
in all implanted spheroids (Fig 6A and S4 Fig). Moreover, Ki-67 immunohistochemical stain-
ing labeled invasive cells in vitro (S4 Fig) and in vivo (data not shown) for all three GSS cul-
tures. Having the vimentin and CD56 tumor cell stainings as a reference, fewer of the invasive
compared to the central tumor cells expressed Ki-67. For U87 a very high Ki-67 LI was found
in both the cultured spheroids (92%) and the tumors in vivo (79%), whereas a lower Ki-67
Histological sections from the mice brains were immunostained with anti-human vimentin and CD56 for
identification of the tumor cells. The survival (O) was recorded and the following measurements were
performed: tumor area (max survival (P) and short survival (Q)), invasion area (short survival (R)) and longest
invasion distance (short survival (R)). Data are shown as means ± SEM, and statistical significance */$
P<0.05, **/$ $ P<0.01, ***/$ $ $ P<0.001 was investigated using ANOVA with Bonferroni correction for
comparison of all groups. $ is comparison of the GSS cultures to U87. Scalebar 2 mm (A-N).
doi:10.1371/journal.pone.0159746.g005
Fig 6. Ki-67 labeling index and scoring of stem cell markers in cultured spheroids, in vivo xenografts and implanted
spheroids. Ki-67 LI (A) was measured in cultured spheroids, in vivo xenografts and implanted spheroids using ki-67 stained
histological sections. A semi-quantitative scoring was performed for CD133 (B) nestin (C) and podoplanin (D). Data are shown as
means ± SEM, n = 4–9 for cultured spheroids, n = 2–12 for in vivo xenografts, n = 5–58 for implanted spheroids, and statistical
significance *P<0.05, **P<0.01, ***P<0.001 was investigated using ANOVA with Bonferroni correction for comparison of all
groups.
doi:10.1371/journal.pone.0159746.g006
Stem-Cell Based Glioblastoma Invasion Model
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expression was found in the spheroids implanted into the brain slice cultures (33%) (Fig 6A).
Interestingly, both T78 and T86 had a high Ki-67 LI in the cultured spheroids (66% and 58%),
whereas a decreased and similar proliferation index were found in the tumors in vivo (35% and
16%) and in the in vitro implanted spheroids (37% and 17%) (Fig 6A). For T87 a different pro-
liferation pattern was seen with the highest Ki-67 LI in the cultured spheroids (46%) and in the
tumors in vivo (52%) compared to the Ki-67 LI in the implanted spheroids (7%) (Fig 6A).
The stem cell markers CD133, nestin and podoplanin were analyzed in the three models
showing different staining patterns both in between the models but also between the GSS cul-
tures used. Due to some co-reactivity of the CD133 and nestin antibodies in mouse and rat tis-
sue a separate evaluation of the protein expression in invasive cells was not performed.
In U87 and T78 a trend towards a higher expression of CD133 was found in the cultured
spheroids, whereas for both T86 and T87 a trend towards a higher CD133 expression in the
tumors in vivo was found (Fig 6B and S5 Fig).
Regarding nestin, a trend towards the highest expression in U87 and T87 was found in the
tumors in vivo, whereas both T78 and T86 showed a similar expression in all three models (Fig
6C and S6 Fig). The nestin expression in the core spheroid and the invasive cells in vitro was
very pronounced for T78, appearing as if most of the tumor cells expressed nestin. A less prom-
inent nestin staining of T86 and T87 invasive cells was found (S6 Fig).
Regarding podoplanin, U87 tumors in vivo displayed only a few positive cells and for both
T78 and T87 no podoplanin expression was found in tumor cells in any of the three models.
T86 showed intense staining in both the tumors in mice and in the implanted spheroids (Fig
6D and S7 Fig). The positive staining identified in T78 and T86 tumors in vivo also comprised
the blood vessels (S7 Fig). In the T86 cultures a few invasive cells stained positive both in vivo
and in vitro, however, the majority of invading cells did not express podoplanin (S7 Fig).
Discussion
In the present study an in vivo-like in vitro invasion model was established using stem cell
medium. The model was based on GSS cultures implanted into rat brain slice cultures. Invasion
in this model was for the first time compared with invasion in vivo and important similarities
were found. However, when comparing the stem cell-like phenotype of the tumor cells in the
three different models, the phenotype was found to vary both between models and GSS cul-
tures. These results suggest that the established in vitro invasion model is a valuable tool in
invasion studies but phenotypic differences in stem cell features may be present between the
models.
In vitro invasion
The in vitro invasion model established in the present study showed invasion patterns compa-
rable with the invasion of tumor cells implanted in vivo suggesting this model to be in vivo-
like. The earlier described circumscribed growth of U87 in vivo [16, 33, 34] in contrast to the
infiltrative growth of the GSS cultures was also demonstrated in the in vitro invasion model
established in the present study adding profound evidence that the model is a valid system to
use for invasion studies. In more traditional in vitro assays like the wound healing assay and
the transwell migration assay, U87 has been described as a migrating cell line [35–37], thereby
suggesting that our model may have an advantage in terms of better mimicking the mecha-
nisms playing a role in vivo. The explanation is most likely due to invasion being a process
with mutual interaction between tumor cells and cells in the brain slices (neurons, astrocytes
and microglial cells) and this is well mimicked in the spheroid-brain slice assay as opposed to
many other assays. Organotypic brain slice cultures implanted with glioma cells have been
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used before [23, 32, 38–43] but the present study is the first to use GSS cultures and stem cell-
like growth conditions incorporating the important stem cell aspect in the model. The stem
cell-like growth condition seemed suitable for brain slice cultures since the main glial and neu-
ronal compartments were preserved like previously shown in brain slice cultures cultured in
conventional serum-free medium with low growth factor concentrations [44, 45]. Furthermore,
the present study is one of the first to use both confocal imaging and subsequent immunohis-
tochemistry confirming convincingly in 3 μm thin histological sections, the findings observed
in the confocal images by quantitative histological methods. Previously, tissue fragments from
biopsy tissue have been implanted into brain slice cultures [39, 43], providing in principle an
even more in vivo-like model with the tumor tissue never being cultured before implantation
into slice cultures. The same is the case when implanting primary organotypic spheroids as
recently reported by our group [23]. The drawback of these approaches is the heterogeneity of
the primary tissue and the limited possibility of repeating the experiments. In contrast using
our approach, GSS spheroids are less heterogenic and can be propagated to large numbers and
used for repeated experimental setups. Moreover neither the model based on tissue fragments
[39, 43] nor the model based on primary spheroids [23] were established using stem cell
medium but instead conventional serum containing medium.
Proliferation and invasion
The tumor cell proliferation measured by the Ki-67 LI seemed to be highly affected by the cul-
turing conditions. For both U87 and the three GSS cultures, the Ki-67 LI was significantly
higher in the cultured spheroids than in the spheroids implanted in vitro into the rat brain slice
culture. T78 and T86 were the cultures most easily implanted into the brain slices and interest-
ingly, the in vivo Ki-67 LI level of these two GSS cultures was also found in the in vitro
implanted spheroids. A decrease in proliferation was expected both in the tumors in vivo and
in the in vitro invasion model compared to free-floating spheroids, since the spheroids were
taken from a culturing condition supporting spheroid formation to a substrate supporting
invasion as previously described [46]. This may be related to the so-called ‘go or grow’ hypoth-
esis stating that proliferation and invasion are two mutually exclusive events [46, 47]. The
hypothesis states that the cells are unable to commit to cell division and migration simulta-
neously, hence temporally migration suppress proliferation and vice versa. This indeed seemed
to be the case for the GSS cultures T78 and T86 when following the tumor cells over time. The
time-lapse movies of invasion suggest that the cells move randomly without any particular
direction, however, the cells stall and becomes immobile upon cell division. In the present
study this takes place in a stem cell medium-based context thereby confirming a previous
observation made using serum containing medium [23].
Comparison of invasion in vitro and in vivo
Upon comparison of invasion distances and area in vivo and in vitro, T87 had the longest inva-
sion distance and largest invasion area in both models. T78 had the second longest invasion
distance in both models closely followed by T86, whereas very limited or no invasion was seen
for U87. The mesenchymal subtype has earlier been associated with aggressiveness and
increased invasion [48]. Despite this, we identified T87, a proneural culture to be the most
invasive. This may be explained by different mechanisms driving invasion within each subtype.
To perform a direct comparison of invasion potential associated with subtype more cultures of
each subtype should be included in future studies. Only a few studies comparing invasion in
vivo and in vitro have been performed previously and to our knowledge not for gliomas. In one
study the invasion of throphoblasts in an in vitro three-dimensional co-culture model was
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performed and found to resemble the in vivo situation [49]. Another study investigated inva-
sion through a matrigel using a series of normal and malignant epithelial and mesenchymal
cells. This study showed that matrigel did not provide a universal model for mimicking inva-
siveness in vivo [50]. Together these studies and the present study seem to suggest that the use
of in vivo-like brain matrix like slice cultures for invasion studies are preferable.
Area and invasion measurements in vitro
We compared spheroid- and invasion area in confocal and immunohistochemical images for
the in vitro invasion model. Regarding spheroid area (Figs 3A and 4A) the area in the confocal
images appeared a little larger than in the immunohistochemical images. These differences are
most likely a result of the confocal images comprising several superimposed images thus corre-
sponding to the total amount of invasive cells, whereas the immunohistochemical images rep-
resent a 3 μm section from a certain level in the spheroid. Diffusion of DiI from the spheroid
into the brain slice might also be part of the explanation [51]. Such diffusion into the brain tis-
sue could be interpreted as an enlarged area and as invasion. Supporting this, U87 showed
invasion in the confocal images (Fig 2A–2C and Fig 3B) but not in the immunohistochemical
images (Fig 4A, 4B, 4J and 4K). Thus subsequent immunohistochemical analysis validating the
invasion seen in the confocal images is important and studies using only confocal imaging
should be interpreted with some caution.
Phenotypes and models
The stem cell markers chosen in the present study to compare the phenotypes in the three dif-
ferent models were CD133, nestin and podoplanin. When first described only CD133 positive
tumor cells were believed to initiate tumors in mice [24]. In the present study the GSS cultures
varied in CD133 expression and even though both the T86 and T87 spheroid cultures had
almost no CD133 expression they were still capable of tumor initiation in vivo. This is sup-
ported by the study by Wang et al. showing tumor initiation by CD133 negative cells [52]. Nes-
tin is expressed in neural stem cells and is believed to be important in proliferation and
invasion [53]. Interestingly, nestin was the only stem cell marker expressed by the invasive
tumor cells of all three GSS cultures suggesting a function of nestin in these cells, which is in
line with previous findings of nestin being important in invasion [53]. Podoplanin was primar-
ily included in the study based on its role in stemness and its potential involvement in invasion
[54]. In this study, however, podoplanin was only found in a few invasive cells in the T86
culture.
The tumors in mice seemed to some extend to express more of the stem cell markers than
both the cultured spheroids and the spheroids implanted into the brain slice cultures. This may
be explained by the complex in vivo microenvironment in the mice brains and mice brain
tumors being best at preserving tumor stem cell features [55–57]. The tumor microenviron-
ment is maintained by several factors like VEGF [58], low oxygen levels [59, 60] and niches of
tumor stem cells [31, 57, 61] playing an important role in regulation of the stem cells. A func-
tional vascular compartment instead of remnants of vessels being present in the slice cultures
[62, 63] may be import for both the VEGF secretion and the function of the perivascular tumor
stem cell niche. Another explanation might be the shorter time course of spheroid development
and invasion in vitro compared with the longer observation time in vivo. Although these expla-
nations represent potential limitations of the brain slice culture model, expression of the stem
cell markers justifies that the model is used in studies focusing on these aspects.
The three GSS cultures were all derived from IDH1-negative tumors but showed differences
in their methylation status and karyotypes supporting the different phenotype of the cultures
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observed in this study. Another important aspect to be stressed is that the GSS cultures most
likely are polyclonal leading to growth and propagation of different cell types dependent on the
models used. Incorporating thereby the therapeutically relevant heterogeneity of glioblastoma
in the established in vitro model, these aspects at the same time suggest that spheroids from dif-
ferent GSS lines should be used for testing novel therapeutic strategies.
Conclusion and perspectives
In conclusion, the advantage of the in vitro invasion model established in the present study is
the in vivo-like invasion and the use of serum-free medium taking the stem-like cell population
into account. The model is feasible and robust and as a strong methodological aspect, it is pos-
sible to investigate the tumor cell invasion and the cellular expression of various markers using
immunohistochemistry. We believe that the established in vivo-like model has a great potential
in screening of new anti-cancer drugs including evaluation of anti-invasive effects into the
screening.
Supporting Information
S1 Fig. Growth curves for GSS cultures and U87. The GSS cultures and U87 were cultured in
serum-free medium as spheroids and trypsinated. Cells were seeded and the cell number esti-
mated in triplicates at day 1–5. The data shown are mean; n = 3. Bars; SEM.
(TIF)
S2 Fig. Cell division in time-lapse movie. Still pictures obtained from the time-lapse movie
with T86 showing a cell becoming immobile after cell division. The pictures were obtained
after 22–24 hours. Arrows show the cell before (A, D), during (B, E) and after cell division (C,
F).
(TIF)
S3 Fig. Expression of glial and neuronal markers in brain slice cultures. Brain slice cultures
were fixed, paraffin embedded, sectioned (3 μm) and immunohistochemically stained for
GFAP (A, D), MAP2 (B, E) and NeuN (C, F). Both the cortex and striatum expressed the astro-
cytic marker GFAP and the neuronal markers MAP2 and NeuN. Scalebar 100 μm.
(TIF)
S4 Fig. Comparison of Ki-67 expression. Ki-67 expression in immunostained sections of cul-
tured spheroids (A, D, G, J), in vivo xenografts (B, E, H, K) and implanted spheroids (C, F, I, L)
from U87 (A-C) and the three GSS cultures (D-L). The outlined areas identify spheroids
implanted into the brain tissue (C, F, I, L). Scalebar 100 μm.
(TIF)
S5 Fig. Comparison of CD133 expression. CD133 expression in immunostained sections of
cultured spheroids (A, D, G, J), in vivo xenografts (B, E, H, K) and implanted spheroids (C, F,
I, L) from U87 (A-C) and the three GSS cultures (D-L). The outlined areas identify tumor
developed in mice (H) and spheroids implanted into the brain tissue (C, F, I, L). Scalebar
100 μm.
(TIF)
S6 Fig. Comparison of nestin expression. Nestin expression in immunostained sections of
cultured spheroids (A, D, G, J), in vivo xenografts (B, E, H, K) and implanted spheroids (C, F,
I, L) from U87 (A-C) and the three GSS cultures (D-L). The outlined areas identify tumor
developed in mice (H) and spheroids implanted into the brain tissue (C, F, I, L). Inserts show
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area indicated by arrow in higher magnification. Scalebar 100 μm.
(TIF)
S7 Fig. Comparison of podoplanin expression. Podoplanin expression in immunostained
sections of cultured spheroids (A, D, G, J), in vivo xenografts (B, E, H, K) and implanted spher-
oids (C, F, I, L) from U87 (A-C) and the three GSS cultures (D-L). The outlined areas identify
tumor developed in mice (H) and spheroids implanted into the brain tissue (C, F, L). Inserts
show area indicated by arrow in higher magnification. Scalebar 100 μm.
(TIF)
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